Clinical Trial Update: Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial is evaluating whether fecal microbiota transplantation can support lymphoma patients treated with axicabtagene ciloleucel therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• Yescarta (axicabtagene ciloleucel) (axicabtagene ciloleucel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: RECRUITING